Relief Therapeutics Holding Stock Probability of Future OTC Stock Price Finishing Over 15.37
| RLFTF Stock | USD 4.33 0.13 2.91% |
Relief |
Relief Therapeutics Target Price Odds to finish over 15.37
The tendency of Relief OTC Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over $ 15.37 or more in 90 days |
| 4.33 | 90 days | 15.37 | near 1 |
Based on a normal probability distribution, the odds of Relief Therapeutics to move over $ 15.37 or more in 90 days from now is near 1 (This Relief Therapeutics Holding probability density function shows the probability of Relief OTC Stock to fall within a particular range of prices over 90 days) . Probability of Relief Therapeutics price to stay between its current price of $ 4.33 and $ 15.37 at the end of the 90-day period is about 66.95 .
Assuming the 90 days horizon the otc stock has the beta coefficient of 1.09 indicating Relief Therapeutics Holding market returns are reactive to returns on the market. As the market goes up or down, Relief Therapeutics is expected to follow. Moreover Relief Therapeutics Holding has an alpha of 1.0854, implying that it can generate a 1.09 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Relief Therapeutics Price Density |
| Price |
Predictive Modules for Relief Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Relief Therapeutics. Regardless of method or technology, however, to accurately forecast the otc stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the otc stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Relief Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Relief Therapeutics Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Relief Therapeutics is not an exception. The market had few large corrections towards the Relief Therapeutics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Relief Therapeutics Holding, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Relief Therapeutics within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 1.09 | |
β | Beta against Dow Jones | 1.09 | |
σ | Overall volatility | 1.71 | |
Ir | Information ratio | 0.1 |
Relief Therapeutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Relief Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Relief Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Relief Therapeutics is way too risky over 90 days horizon | |
| Relief Therapeutics appears to be risky and price may revert if volatility continues | |
| Relief Therapeutics has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 3.32 M. Net Loss for the year was (34.7 M) with profit before overhead, payroll, taxes, and interest of 2.57 M. | |
| Relief Therapeutics Holding has accumulated about 29.87 M in cash with (35.72 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01. | |
| Latest headline from investing.com: Aileron Therapeutics CEO James Brian Windsor buys 897 in stock |
Relief Therapeutics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Relief OTC Stock often depends not only on the future outlook of the current and potential Relief Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Relief Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 4.1 B |
Relief Therapeutics Technical Analysis
Relief Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. Relief OTC Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Relief Therapeutics Holding. In general, you should focus on analyzing Relief OTC Stock price patterns and their correlations with different microeconomic environments and drivers.
Relief Therapeutics Predictive Forecast Models
Relief Therapeutics' time-series forecasting models is one of many Relief Therapeutics' otc stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Relief Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the otc stock market movement and maximize returns from investment trading.
Things to note about Relief Therapeutics
Checking the ongoing alerts about Relief Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Relief Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Relief Therapeutics is way too risky over 90 days horizon | |
| Relief Therapeutics appears to be risky and price may revert if volatility continues | |
| Relief Therapeutics has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 3.32 M. Net Loss for the year was (34.7 M) with profit before overhead, payroll, taxes, and interest of 2.57 M. | |
| Relief Therapeutics Holding has accumulated about 29.87 M in cash with (35.72 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01. | |
| Latest headline from investing.com: Aileron Therapeutics CEO James Brian Windsor buys 897 in stock |
Other Information on Investing in Relief OTC Stock
Relief Therapeutics financial ratios help investors to determine whether Relief OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Relief with respect to the benefits of owning Relief Therapeutics security.